Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BYDiagnostics (Basel, Switzerland)

Comparative Detection of IDH1 R132H and TERT Promoter Mutations in Plasma and Cerebrospinal Fluid of Patients with Glioma Using Targeted Droplet Digital PCR

  • Mark Jain1
  • Tagir Rahmatullin1
  • Ivan Alexeev2
  • Ariadna Gomershtat3
  • Margarita Gundobina3
  • Larisa Samokhodskaya1
  • Andrey Zuev2
  1. 1University Clinic, , 119992 Moscow, Russia; (T.R.); (L.S.)
  2. 2National Medical and Surgical Center Named After N.I. Pirogov, 105203 Moscow, Russia; (I.A.); (A.Z.)
  3. 3Faculty of Fundamental Medicine, , 119992 Moscow, Russia; (A.G.); (M.G.)
Read full textPDFCite

Related

  1. Urinary TERT promoter mutations as non-invasive biomarkers for the comprehensive detection of urothelial cancer
    Patrice Hodonou Avogbe, Arnaud Manel, Emmanuel Vian +22
    EBioMedicinePeer-reviewedCC BY-NC-NDFull text76 citedGeneral biologyOncologyHAL
  2. Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary TERT Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
    Md Ismail Hosen, Nathalie Forey, Geoffroy Durand +23
    CancersPeer-reviewedCC BYFull text47 citedGeneral biologyOncologyHAL
  3. Molecular and Lifestyle Determinants of Oral Squamous Cell Carcinoma in Bangladesh: Dietary Patterns Independent of HPV and TERT Promoter Mutations
    Rokhshana Akter Liza, Enayetur Raheem, Sonia Akter +6
    Asian Pacific Journal of Cancer Prevention : APJCPPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
  4. Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.
    Md Ismail Hosen, Mahdi Sheikh, Maria Zvereva +26
    EBioMedicinePeer-reviewedCC BY-NC-NDFull text92 citedGeneral biologyOncologyHAL
  5. Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations
    Xian-Zhao Deng, Meng-yue Liu, Chen-Tian Shen +7
    Frontiers in oncologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{jain2026comparative,
  title = {{Comparative Detection of IDH1 R132H and TERT Promoter Mutations in Plasma and Cerebrospinal Fluid of Patients with Glioma Using Targeted Droplet Digital PCR}},
  author = {Mark Jain and Tagir Rahmatullin and Ivan Alexeev and Ariadna Gomershtat and Margarita Gundobina and Larisa Samokhodskaya and Andrey Zuev},
  journal = {Diagnostics (Basel, Switzerland)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13703826},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Comparative Detection of IDH1 R132H and TERT Promoter Mutations in Plasma and Cerebrospinal Fluid of Patients with Glioma Using Targeted Droplet Digital PCR
AU  - Mark Jain
AU  - Tagir Rahmatullin
AU  - Ivan Alexeev
AU  - Ariadna Gomershtat
AU  - Margarita Gundobina
AU  - Larisa Samokhodskaya
AU  - Andrey Zuev
PY  - 2026
DA  - 2026/10/01
JO  - Diagnostics (Basel, Switzerland)
UR  - https://europepmc.org/article/PMC/PMC13703826
SN  - 2075-4418
ER  -